REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/22/2025
Back to search
Official data from USPTO
CYCAT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
09/23/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
09/14/2019
Registration date
09/22/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/22/2020
Last transaction
09/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Planegg, DE
Examiner
POWERS, ALEXANDER
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MorphoSys AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Antibodies for scientific purposes and not for medical or veterinary use; Monoclonal antibodies for diagnostic use and not for medical or veterinary use; Biochemicalsmonoclonal antibodies for scientific or research use; Tagged antibodies for scientific and laboratory use; immunological antibodies not for medical use; Reagents for use in the development of monoclonal antibodies not for medical or veterinary purposes; biological and biotechnological products used in industry and scienceantibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations; biological preparations for laboratoriesfor diagnosticsfor analysis and environmental analysisother than for medical or veterinary use
Class 5
Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disordersinfectious diseasescancerinflammatory diseasesautoimmune diseasesAlzheimersepsisrestenosis; diagnostic antibodies for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disordersinfectious diseasescancerinflammatory diseasesautoimmune diseasesAlzheimersepsisrestenosis; medical diagnostic reagents; clinical medical reagents; Biological preparations for medical and veterinary purposes for the treatment of metabolic disordersinfectious diseasescancerinflammatory diseasesautoimmune diseasesAlzheimersepsisrestenosis; biological preparations for medical and veterinary purposesantibodies sold as a component ingredient of pharmaceuticals
Class 42
Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological servicesscientific researchanalysistesting services in the fields of analytical chemistrybiochemistrymedicinal chemistrydrug developmentbiotechnologymicrobiology and molecular biology; biological research; clinical research in connection with the treatment and prevention of metabolic disordersinfectious diseasescancerinflammatory diseasesautoimmune diseasesAlzheimersepsisrestenosis; medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistrybiochemistrymedicinal chemistrydrug developmentbiotechnologymicrobiology and molecular biology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of pharmaceuticals; research and development services in the field of antibodies
Publications
History of USPTO decisions and trademark events.
26 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/21/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/21/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/21/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/21/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/21/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/21/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
09/22/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2020
PUBO
PUBLISHED FOR OPPOSITION
07/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/17/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
06/04/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
05/29/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/27/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/27/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/25/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/18/2019
GNRT
NON-FINAL ACTION E-MAILED
12/18/2019
CNRT
NON-FINAL ACTION WRITTEN
12/18/2019
DOCK
ASSIGNED TO EXAMINER
12/15/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/22/2019
ALIE
ASSIGNED TO LIE
11/21/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/17/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/23/2019
NWAP
NEW APPLICATION ENTERED
09/18/2019
Continuous trademark protection
Get notified about every new filing that threatens CYCAT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.